The uncertain path to authorisation in the US for Novavax despite passing the efficacy test with an impressive score of 90.4% might see India emerge as a major destination for the shots with the Serum Institute of India as manufacturing partner.
source https://timesofindia.indiatimes.com/india/covid-19-novavax-set-for-india-launch-with-serum-institute-of-india-as-manufacturing-partner/articleshow/83524029.cms
source https://timesofindia.indiatimes.com/india/covid-19-novavax-set-for-india-launch-with-serum-institute-of-india-as-manufacturing-partner/articleshow/83524029.cms
Comments
Post a Comment